PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
101 hedge funds and large institutions have $136M invested in Poseida Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
40% less capital invested
Capital invested by funds: $226M → $136M (-$90.2M)
Holders
101
Holding in Top 10
2
Calls
$182K
Puts
$30K
Top Buyers
| 1 | +$2.5M | |
| 2 | +$1.47M | |
| 3 | +$1.41M | |
| 4 |
Two Sigma Investments
New York
|
+$1.28M |
| 5 |
Renaissance Technologies
New York
|
+$1.25M |
Top Sellers
| 1 | -$4.31M | |
| 2 | -$4.2M | |
| 3 | -$2.07M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.62M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.54M |